Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 最近診断された心房細動の患者の心不全: Gloria- Af レジストリフェーズiiiからの発見
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 最近診断された心房細動の患者の心不全: Gloria- Af レジストリフェーズiiiからの発見

関連する実験動画

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

最近診断された心房細動の患者の心不全: GLORIA- AF レジストリフェーズIIIからの発見

Bernadette Corica1,2, Giulio Francesco Romiti1,3, Marco Proietti4,5

  • 1Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, 6 West Derby Street, L7 8TX, Liverpool, UK.

European journal of preventive cardiology
|August 31, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

閉塞性心不全 (CHF) は,心房細動 (AF) の患者で一般的であり,より悪い結果につながります. こうした複雑な AF-CHF 症例では 改善された介入が必要である.

キーワード:
心房細動流行病学心不全死亡率

さらに関連する動画

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

関連する実験動画

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

科学分野:

  • 心臓病科
  • 臨床流行病学

背景:

  • 閉塞性心不全 (CHF) はしばしば心房細動 (AF) と共存する.
  • この関連性の臨床的流行病学,管理,および結果については,まだ完全に理解されていません.
  • 併発性CHFのAF患者を理解するために,実際のデータは非常に重要です.

研究 の 目的:

  • 冠動脈不全の患者と非冠動脈不全の患者の特徴,治療方法,結果を分析する.
  • AF患者におけるCHFと関連した因子を特定する.
  • 経口抗凝固剤 (OAC) の使用と長期的な有害事象に対するCHFの影響を評価する.

主な方法:

  • 最近AFと診断され,CHA2DS2- VAScスコアが1以上であった成人患者21,125人を含む,GLORIA- AFレジスタリフェーズIIIのデータ分析.
  • CHF,OACの使用,および他の治療法に関連する要因の評価.
  • 多変量コックス回帰を用いた3年間のフォローアップにおける,複合的なプライマリアウトカム (あらゆる原因による死亡,MACE) と二次的なアウトカムの評価

主要な成果:

  • AF患者の21. 9% (n=4632) が心筋梗塞を発症した.
  • 左心室射出分数 (LVEF) ≤40%のCHF患者は,OAC (OR1. 47) を受ける確率が高かった.
結果
  • CHFは,プライマリアウトカム (HR2. 04) のリスク増加と有意に関連しており,LVEF ≤40%の患者ではリスク増加がより高い.
  • 結論:

    • 閉塞性心不全は現実世界における心不全患者で一般的であり,より複雑な臨床的状況を示しています.
    • CHFのAF患者は異なる管理パターンを示し,より悪い予後に直面します.
    • AFとCHFの両方の患者の予後を改善するために,標的を絞った介入が必要である.